Thus, to the best of our knowledge, in this study, we report for the first time the predictive value of the immunohistochemical (IHC) status of leptin, leptin-R, adiponectin, and resistin together on tumor characteristics and outcomes in a cohort of 81 RCC patients who were treated with nephrectomy. The gene discussed is RETN; the disease is neoplasm.